Clinical trials
Observational Gastrointestinal Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Region Örebro County | 3 |
| Renmin Hospital of Wuhan University | 3 |
| Assiut University | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| Weill Medical College of Cornell University | 2 |
| Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | 1 |
| All India Institute of Medical Sciences | 1 |
| Beijing 302 Hospital | 1 |
| Beijing Friendship Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Diseases | 35 |
| Digestive System Diseases | 6 |
| Gastrointestinal Neoplasms | 6 |
| Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Digestive System Neoplasms | 5 |
| Irritable Bowel Syndrome | 5 |
| Intestinal Diseases | 4 |
| Intestinal Neoplasms | 3 |
| Neoplasms by Site | 3 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.